Proficio Capital Partners LLC Neurocrine Biosciences Inc Transaction History

Proficio Capital Partners LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 19, 2023	BUY	$94.11 - $123.02 $1.02 Million - $1.33 Million	10,831 New	10,831 $1.1 Million
Q3 2019 Nov 13, 2019	SELL	$83.82 - $101.5 $8,884 - $10,759	-106 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$72.24 - $91.27 $2,817 - $3,559	39 Added 58.21%	106 $9,000
Q1 2019 May 13, 2019	BUY	$69.31 - $91.53 $415 - $549	6 Added 9.84%	67 $6,000
Q4 2017 Feb 09, 2018	BUY	$58.53 - $77.59 $292 - $387	5 Added 8.93%	61 $5,000
Q3 2017 Nov 14, 2017	BUY	$47.97 - $61.28 $2,686 - $3,431	56	56 $3,000

625

94.2M

632K

621K

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $12B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

Get notified when there are updates to the investment portfolio of Proficio Capital Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Proficio Capital Partners LLC with notifications on news.